CXCL1 and prostate carcinoma: In murine models of squamous cell carcinoma and Lewis lung cancer CXCL1 expression was shown to parallel tumor growth [28,39] and in adrenocortical and prostate carcinoma [40,41] as well as in melanoma [29,42,43] CXCL1 was shown to mediate tumorigenicity.